Tech Company Financing Transactions
Pangea Biomed Funding Round
Pangea Biomed secured a $7 million Seed venture capital round on 4/7/2022. Investors included NFX.
Transaction Overview
Company Name
Announced On
4/7/2022
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Seed
Investors
NFX (Lead Investor)
Proceeds Purpose
Funding will be used to grow its research and development team, and expand its partnerships and commercial collaborations to support in designing
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2A HaBarzel St.
Tel Aviv, Undisclosed
Israel
Tel Aviv, Undisclosed
Israel
Phone
Undisclosed
Website
Email Address
Overview
Pangea Biomed is an RNA-focused precision oncology biotech company on a mission to redefine cancer care. This will be achieved by significantly accelerating drug discovery and development, charting a highly personalized treatment course for each patient, and improving clinical efficiency and outcomes.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Tuvik Beker
Chairman
Eyal Schiff
Chief Operating Officer
Emmanuel Elalouf
Chief Technical Officer
Ranit Aharonov
Co-Founder
Ze'ev Ronai
Browse more venture capital transactions:
Prev: 4/7/2022: Flow Club venture capital transaction
Next: 4/7/2022: Covr Financial Technologies venture capital transaction
Share this article
News on VC Transactions
We do our best to record every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs